These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate, and -resistant Staphylococcus aureus. Fritsche TR; Rhomberg PR; Sader HS; Jones RN Diagn Microbiol Infect Dis; 2008 Apr; 60(4):399-403. PubMed ID: 18178361 [TBL] [Abstract][Full Text] [Related]
11. [Detection methods for drug-resistant bacteria in routine examination--VISA]. Kinoshita S; Nakamachi Y Rinsho Byori; 2000 Jan; Suppl 111():69-74. PubMed ID: 10804795 [TBL] [Abstract][Full Text] [Related]
12. Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus. Pillai SK; Wennersten C; Venkataraman L; Eliopoulos GM; Moellering RC; Karchmer AW Clin Infect Dis; 2009 Oct; 49(8):1169-74. PubMed ID: 19769538 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus. Barcia-Macay M; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F J Antimicrob Chemother; 2006 Dec; 58(6):1177-84. PubMed ID: 17062609 [TBL] [Abstract][Full Text] [Related]
14. Emergence of a small colony variant of vancomycin-intermediate Staphylococcus aureus in a patient with septic arthritis during long-term treatment with daptomycin. Lin YT; Tsai JC; Yamamoto T; Chen HJ; Hung WC; Hsueh PR; Teng LJ J Antimicrob Chemother; 2016 Jul; 71(7):1807-14. PubMed ID: 26968883 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and clinical implications of Staphylococcus aureus with a vancomycin MIC of 4 microg/ml in Korea. Kim HB; Lee YS; Kim BS; Cha JO; Kwon SU; Lee HJ; Suh JT; Rheem I; Kim JM; Shin BM; Kim MN; Lee K; Lee CS; Kim EC; Oh MD; Choe KW Microb Drug Resist; 2006; 12(1):33-8. PubMed ID: 16584306 [TBL] [Abstract][Full Text] [Related]
16. Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan. Huang YT; Hsiao CH; Liao CH; Lee CW; Hsueh PR J Clin Microbiol; 2008 Mar; 46(3):1132-6. PubMed ID: 18199793 [TBL] [Abstract][Full Text] [Related]
17. Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia. Sakoulas G; Gold HS; Cohen RA; Venkataraman L; Moellering RC; Eliopoulos GM J Antimicrob Chemother; 2006 Apr; 57(4):699-704. PubMed ID: 16464892 [TBL] [Abstract][Full Text] [Related]
18. Vancomycin MICs did not creep in Staphylococcus aureus isolates from 2002 to 2006 in a setting with low vancomycin usage. Alós JI; García-Cañas A; García-Hierro P; Rodríguez-Salvanés F J Antimicrob Chemother; 2008 Oct; 62(4):773-5. PubMed ID: 18552338 [TBL] [Abstract][Full Text] [Related]
19. In vitro activity of fluoroquinolones, vancomycin, and gentamicin against methicillin-resistant Staphylococcus aureus ocular isolates. Kotlus BS; Wymbs RA; Vellozzi EM; Udell IJ Am J Ophthalmol; 2006 Nov; 142(5):726-9. PubMed ID: 17056356 [TBL] [Abstract][Full Text] [Related]